ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2007

Periodontal Pockets as a Potential Source of Circulating TREM-1 and Its Ligand PGLYRP1 in Patients with Rheumatoid Arthritis

Nevsun Inanc1, GONCA MUMCU 2, Meryem Can 3, Haner Direskeneli 4 and Nagihan Bostanci 5, 1Marmara University, Faculty of Medicine, Division of Rheumatology, Istanbul, Turkey, ISTANBUL, Turkey, 2Marmara, University, Department of Health Management, Marmara University School of Health Sciences, Istanbul, Turkey, ISTANBUL, Turkey, 3Marmara University, Division of Rheumatology, Istanbul, Turkey, Istanbul, Turkey, 4Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey, 5Section of Periodontology and Dental Hygiene, Division of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pathogenesis, Periodontitis and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: PGLYRP1, a member of peptidoglycan recognition proteins is a putative ligand as a ligand for triggering receptor expressed on myeloid cells-1 (TREM-1) which is involved in amplifying pro-inflammatory processes in chronic inflammatory diseases. However, the presence of circulating PGLYRP1 in patients with rheumatoid arthritis (RA) who suffer from periodontal disease is currently unknown.

The aim of the study was to investigate the association of circulating TREM-1 and its ligand PGLYRP1 with oral inflammatory/infection burden among patients with rheumatoid arthritis (RA). 

Methods: The study population was recruited among individuals diagnosed with RA  who were under sDMARD treatment for more than 6 months and never used biologic treatment (n=65, (F/M: 45/17) at the Department of Rheumatology, Faculty of Medicine, Marmara University, Turkey. 43 patients with Behcet syndrome (BS, F/M: 31/12) and 59 systemically healthy subjects (HC, F/M: 40/19) were assessed as controls.  Serum and saliva samples were collected on the same day of oral health and musculoskeletal examination. RA disease activity was assessed using 28- joint disease activity score (DAS-28). Oral health was evaluated by dental and periodontal indices. Salivary levels of cumulative bacterial load and individual species including S.oralis, A.oris, F.nucleatum, P.intermedia, A.actinomycetemcomitans, T.denticola, P.gingivalis, and T.forsthia were analyzed by quantitative real-time polymerase chain reaction (qPCR). sTREM-1 and PGLYRP1 levels in serum were analyzed by ELISA.

Results: Elevated sTREM-1 and PGLYRP1 levels in serum was observed in RA (167,1±95,0 pg/ml; 157,5±228,8 pg/ml) than BD (102,8±44,4 pg/ml; 52,4±26,01pg/ml) and HC (90,7±56,5 pg/ml; 68,8±37,7 pg/ml) (p< 0.05)(Table 1). RA patients presented with significantly higher total bacterial load (p< 0.05) compared to the HC group. Tooth loss was significantly higher in RA (18.67±8.45) compared to those of BD (24.02±3.7) and HC (25.36±3.83)(p=0.001 and p=0.000) (Table 2). In RA, sTREM-1 and PGLYRP1 levels were significantly higher in patients with severe periodontitis (219,1±107,9 pg/ml and 265,6±336,7 pg/ml) than the others (133,9±68,9 and 87,1±55,3 pg/ml) (p=0.006; p=0.01, respectively) (Table 3).

Conclusion: Serum sTREM-1 and its ligand PGLYRP1 levels were higher in patients with RA than BD and HC and especially were higher in patients with severe periodontitis. In addition, increased tooth loss and higher total bacterial load were associated with RA.


ACR-2019-DRAFT_NB Nİ -table 1-pdf-

Table 1: Serum TREM-1 and Related Factors in Patients with RA and Controls


ACR-2019-DRAFT_NB Nİ -table 2 PDF-

Table 2: Oral Health in Patients with RA and Behçet’s Syndrome and Healthy Controls


ACR-2019-DRAFT_NB Nİ -table 3 PDF-

Table 3: Serum TREM-1 and PGLYRP-1 Levels According to Severe Periodontitis in RA


Disclosure: N. Inanc, None; G. MUMCU, None; M. Can, None; H. Direskeneli, None; N. Bostanci, None.

To cite this abstract in AMA style:

Inanc N, MUMCU G, Can M, Direskeneli H, Bostanci N. Periodontal Pockets as a Potential Source of Circulating TREM-1 and Its Ligand PGLYRP1 in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/periodontal-pockets-as-a-potential-source-of-circulating-trem-1-and-its-ligand-pglyrp1-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/periodontal-pockets-as-a-potential-source-of-circulating-trem-1-and-its-ligand-pglyrp1-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology